ZA852316B - Pharmaceutical composition and method for treatment or prophylaxis of cardiac disorders - Google Patents

Pharmaceutical composition and method for treatment or prophylaxis of cardiac disorders

Info

Publication number
ZA852316B
ZA852316B ZA852316A ZA852316A ZA852316B ZA 852316 B ZA852316 B ZA 852316B ZA 852316 A ZA852316 A ZA 852316A ZA 852316 A ZA852316 A ZA 852316A ZA 852316 B ZA852316 B ZA 852316B
Authority
ZA
South Africa
Prior art keywords
prophylaxis
treatment
pharmaceutical composition
cardiac disorders
cardiac
Prior art date
Application number
ZA852316A
Other languages
English (en)
Inventor
Agustin Escobar
Dietmar M Wagenknecht
Ahmad Waseem Malick
Original Assignee
American Hospital Supply Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Hospital Supply Corp filed Critical American Hospital Supply Corp
Publication of ZA852316B publication Critical patent/ZA852316B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • H—ELECTRICITY
    • H04—ELECTRIC COMMUNICATION TECHNIQUE
    • H04L—TRANSMISSION OF DIGITAL INFORMATION, e.g. TELEGRAPHIC COMMUNICATION
    • H04L65/00—Network arrangements, protocols or services for supporting real-time applications in data packet communication
    • H04L65/1066—Session management
    • H04L65/1083—In-session procedures
    • H04L65/1095—Inter-network session transfer or sharing

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Business, Economics & Management (AREA)
  • General Business, Economics & Management (AREA)
  • Multimedia (AREA)
  • Computer Networks & Wireless Communication (AREA)
  • Signal Processing (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA852316A 1984-04-09 1985-03-27 Pharmaceutical composition and method for treatment or prophylaxis of cardiac disorders ZA852316B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US59806184A 1984-04-09 1984-04-09

Publications (1)

Publication Number Publication Date
ZA852316B true ZA852316B (en) 1985-11-27

Family

ID=24394068

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA852316A ZA852316B (en) 1984-04-09 1985-03-27 Pharmaceutical composition and method for treatment or prophylaxis of cardiac disorders

Country Status (9)

Country Link
US (1) US5017609A (ja)
EP (1) EP0179808B1 (ja)
JP (1) JPH0720861B2 (ja)
AU (1) AU575153B2 (ja)
CA (1) CA1242395A (ja)
DE (1) DE3584560D1 (ja)
IT (1) IT1184271B (ja)
WO (1) WO1985004580A1 (ja)
ZA (1) ZA852316B (ja)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4857552A (en) * 1988-06-08 1989-08-15 E. I. Du Pont De Nemours And Co. Stable pharmaceutical composition
GR1000509B (el) * 1988-06-08 1992-07-30 Du Pont Μεθοδος παρασκευης σταθερης ενεσιμης υδατικης συνθεσεως υδροχλωρικου 3-[4-(2-υδροξυ-3-ισοπροπυλαμινο) προποξυ]-φαινυλοπροπιονικου μεθυλεστερα.
US6310094B1 (en) * 2001-01-12 2001-10-30 Baxter International Inc. Ready-to-use esmolol solution
CA2461349C (en) * 2001-09-26 2011-11-29 Baxter International Inc. Preparation of submicron sized nanoparticles via dispersion and solvent or liquid phase removal
US7112340B2 (en) * 2001-10-19 2006-09-26 Baxter International Inc. Compositions of and method for preparing stable particles in a frozen aqueous matrix
WO2005105148A2 (en) * 2004-04-07 2005-11-10 Ares Trading S.A.- Liquid growth hormone formulation
AU2005266449B2 (en) * 2004-07-30 2009-10-08 Novartis Ag Compound formulations of 2-amino-1,3-propanediol compounds
MX2007015183A (es) * 2005-06-14 2008-02-19 Baxter Int Formulaciones farmaceuticas para minimizar las interacciones farmaco-farmaco.
KR20080080119A (ko) * 2005-11-15 2008-09-02 백스터 인터내셔널 인코포레이티드 리폭시게나제 억제제의 조성물
WO2008080047A2 (en) * 2006-12-23 2008-07-03 Baxter International Inc. Magnetic separation of fine particles from compositions
US8426467B2 (en) * 2007-05-22 2013-04-23 Baxter International Inc. Colored esmolol concentrate
AU2014203121B2 (en) * 2007-05-22 2016-04-21 Baxter Healthcare Sa Concentrate esmolol
US20080293814A1 (en) * 2007-05-22 2008-11-27 Deepak Tiwari Concentrate esmolol
US8722736B2 (en) * 2007-05-22 2014-05-13 Baxter International Inc. Multi-dose concentrate esmolol with benzyl alcohol
WO2009079679A2 (de) * 2007-12-21 2009-07-02 Aop Orphan Pharmaceuticals Ag Pharmazeutische zusammensetzung
PT2480204E (pt) 2009-09-22 2014-01-22 Vlife Sciences Technologies Pvt Ltd Formulação tópica para úlceras do pé diabético
EP2667866B1 (en) 2011-01-27 2015-05-20 Baxter International Inc Use of (s)-esmolol for controlling venous irritation associated with the treatment of a cardiac disorder
CN103338763A (zh) 2011-01-27 2013-10-02 巴克斯特国际公司 治疗心动过速和/或控制心率同时最小化和/或控制低血压的方法
CN104473869A (zh) * 2014-11-20 2015-04-01 北京京科泰来科技有限公司 一种艾司洛尔脂肪乳及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3637852A (en) * 1963-08-26 1972-01-25 Boehringer Sohn Ingelheim 1-phenoxy-2-hydroxy-3-isopropylamino-propanes and salts thereof
DE1643262C3 (de) * 1967-12-13 1975-06-26 C.H. Boehringer Sohn, 6507 Ingelheim i-Phenoxy^-hydroxy-S-alklyaminopropane, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
US4191765A (en) * 1976-05-25 1980-03-04 Hoechst Aktiengesellschaft 1-Aryloxy-2-hydroxy-3-aminopropanes
US4146630A (en) * 1976-11-12 1979-03-27 Boehringer Mannheim Gmbh Blood pressure lowering and adrenergic β-receptor inhibiting 3-(4-phenoxymethylpiperidino)-propyl-phenyl ethers
DE2905877A1 (de) * 1979-02-16 1980-08-28 Boehringer Mannheim Gmbh Neue aminopropanolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3015991A1 (de) * 1980-04-25 1981-11-05 C.H. Boehringer Sohn, 6507 Ingelheim Neue 1-aryloxy-3-alkylamino-2-propanole und verfahren zur ihrer herstellung
SE8004087L (sv) * 1980-06-02 1981-12-03 Haessle Ab Nya parasubstituerade 3-fenoxi-1-alkylaminopropanol-2-er med betareceptorblockerande egenskaper, samt forfarande for deras framstellning, farmaceutiska beredningar innehallande desamma, och metod att behandla akut ...
US4387103A (en) * 1980-11-28 1983-06-07 American Hospital Supply Corporation Method for treatment or prophylaxis of cardiac disorders
US4829086A (en) * 1984-03-14 1989-05-09 Bodor Nicholas S Soft β-adrenergic blocking agents

Also Published As

Publication number Publication date
IT1184271B (it) 1987-10-22
JPS61501775A (ja) 1986-08-21
CA1242395A (en) 1988-09-27
WO1985004580A1 (en) 1985-10-24
AU4150785A (en) 1985-11-01
EP0179808A4 (en) 1987-10-27
DE3584560D1 (de) 1991-12-05
US5017609A (en) 1991-05-21
EP0179808B1 (en) 1991-10-30
JPH0720861B2 (ja) 1995-03-08
EP0179808A1 (en) 1986-05-07
IT8547927A0 (it) 1985-04-05
AU575153B2 (en) 1988-07-21

Similar Documents

Publication Publication Date Title
IL83925A0 (en) Compositions for treatment of skin disorders
ZA852316B (en) Pharmaceutical composition and method for treatment or prophylaxis of cardiac disorders
DE3574228D1 (en) Rate scanning demand pacemaker and method for treatment of tachycardia
GB2188844B (en) Pharmaceutical composition for the treatment of psoriasis
HK107594A (en) Treatment of skin disorders
EG16108A (en) Method for treatment or prophylaxis of cardiac disorders
IL76071A0 (en) Method and composition for treatment of cancer
IL77083A (en) Pharmaceutical compositions containing certain n-acyl-histidyl-prolinamide derivatives or salts thereof for the treatment of amyothropic lateral sclerosis and manufacture thereof
ZA817891B (en) Method for treatment or prophylaxis of cardiac disorders
AU7896781A (en) Method for treatment or prophylaxis of cardiac disorders
GB8428747D0 (en) Products for treatment of human body
ZA817931B (en) Compounds and method for treatment or prophylaxis of cardiac disorders
ZA845271B (en) Pharmaceutical and veterinary compositions for the treatment of ischemic cardiac disorders
GB2204488B (en) Pharmaceutical compositions for the treatment or prophylaxis of skin disorders
AU591107B2 (en) Psoralene-based bath compositions for treatment of skin disorders
GB2170403B (en) Medicament for treatment of asthma and preparation thereof
GB2205743B (en) Cosmetic method and composition for prevention and/or treatment of dandruff
GB8715914D0 (en) Treatment of cerabral disorders
ZA855613B (en) Composition and method for the treatment of hemorrhoids
DE3173674D1 (en) Compounds and method for treatment or prophylaxis of cardiac disorders
ZA881828B (en) Preparation for treatment of skin disorders
ZA888338B (en) Pharmaceutical compositions and method of treatment
GB8311803D0 (en) Treatment of seizure disorders and pharmaceutical compositions
IE842027L (en) Treatment of skin disorders
AU8066187A (en) Method and therapeutic compositions for the treatment of bleeding disorders